Skip to content
Primaquine
Primaquine is a small molecule pharmaceutical. Primaquine was first approved as Aralen phosphate w/ primaquine phosphate on 1982-01-01. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA.
Download report
Favorite
COVID-19
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chloroquine phosphate
+
Primaquine phosphate
Tradename
Company
Number
Date
Products
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATESanofiN-014860 DISCN1982-01-01
1 products
Hide discontinued
Primaquine phosphate
Tradename
Company
Number
Date
Products
PRIMAQUINESanofiN-008316 RX1982-01-01
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
primaquine phosphateANDA2022-08-19
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
falciparum malariaEFO_0007444D016778B50
malariaEFO_0001068D008288B54
vivax malariaEFO_0007445D016780B51
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
P01: Antiprotozoals
P01B: Antimalarials
P01BA: Aminoquinoline antimalarials
P01BA03: Primaquine
HCPCS
No data
Clinical
Clinical Trials
91 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalariaD008288EFO_0001068B5468911736
Vivax malariaD016780EFO_0007445B5128109834
Falciparum malariaD016778EFO_0007444B501758523
Glucosephosphate dehydrogenase deficiencyD005955EFO_000728721227
Parasitic diseasesD010272EFO_0001067B8811
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RecurrenceD0120081112
Hiv infectionsD015658EFO_0000764B20112
Pneumocystis pneumoniaD011020EFO_0007448B59112
Asymptomatic diseasesD058070122
Covid-19D000086382U07.1111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients414
PharmacokineticsD010599111
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ParasitemiaD01851211
FavismD005236D55.011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePRIMAQUINE
INNprimaquine
Description
Primaquine is an N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia. It has a role as an antimalarial. It is an aminoquinoline, a N-substituted diamine and an aromatic ether.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1cc(NC(C)CCCN)c2ncccc2c1
Identifiers
PDB
CAS-ID90-34-6
RxCUI
ChEMBL IDCHEMBL506
ChEBI ID8405
PubChem CID4908
DrugBankDB01087
UNII IDMVR3634GX1 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 6,897 documents
View more details
Safety
Black-box Warning
Black-box warning for: Primaquine phosphate
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
41 adverse events reported
View more details